Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学ROS1 Fusion Resistance Mechanisms

Benjamin Besse

MD, PhD

🏢Gustave Roussy Cancer Campus🌐France

Head, Cancer Medicine Department

88
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Benjamin Besse leads the cancer medicine department at Gustave Roussy and has contributed extensively to ROS1-positive NSCLC clinical research. His work on resistance to ROS1 inhibitors and potential immunotherapy combinations has informed sequential treatment strategies. He is a key opinion leader in European thoracic oncology.

Share:

🧪Research Fields 研究领域

ROS1 fusions
Resistance mechanisms
Immunotherapy
NSCLC treatment
European oncology

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Benjamin Besse 的研究动态

Follow Benjamin Besse's research updates

留下邮箱,当我们发布与 Benjamin Besse(Gustave Roussy Cancer Campus)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment